1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Russia Haematology Market Outlook to 2021

Russia Haematology Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 44 pages

Russia Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "Russia Haematology Market Outlook to 2021", provides key market data on the Russia Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the Russia Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Russia Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Haematology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Haematology Market, Russia 9
3.1 Haematology Market, Russia, Revenue ($m), 2007-2014 9
3.2 Haematology Market, Russia, Revenue ($m), 2014-2021 11
3.2.1 Haematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Haematology Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Haematology Reagents Market, Russia, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Haemostasis Market, Russia, Revenue ($m), by Segment, 2007-2014 19
3.2.5 Immunohaematology Market, Russia, Revenue ($m), by Segment, 2007-2014 21
3.2.6 Haematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2014-2021 23
3.2.7 Haematology Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2014-2021 25
3.2.8 Haematology Reagents Market, Russia, Revenue ($m), by Segment, 2014-2021 27
3.2.9 Haemostasis Market, Russia, Revenue ($m), by Segment, 2014-2021 29
3.2.10 Immunohaematology Market, Russia, Revenue ($m), by Segment, 2014-2021 31
3.3 Haematology Market, Russia, Distribution Share by Revenue ($m), 2013-2014 33
3.4 Haematology Market, Russia, Company Share by Revenue ($m), 2014 34
4 Overview of Key Companies in Russia, Haematology Market 36
4.1 Siemens Healthcare 36
4.1.1 Company Overview 36
4.2 Sysmex Corporation 36
4.2.1 Company Overview 36
4.3 Danaher Corporation 36
4.3.1 Company Overview 36
4.4 Abbott Laboratories 37
4.4.1 Company Overview 37
4.5 F. Hoffmann-La Roche Ltd. 37
4.5.1 Company Overview 37
5 Haematology Market Pipeline Products 38
6 Financial Deals Landscape 39
6.1 Partnerships 39
6.1.1 Orphee Terminates Distribution Agreement with PZ Cormay 39
6.1.2 NoemaLife Enters into Distribution Agreement with Horiba Medical 40
7 Appendix 41
7.1 Research Methodology 42
7.1.1 Coverage 42
7.1.2 Secondary Research 42
7.1.3 Primary Research 43
7.1.4 Company Share Analysis 43
7.1.5 Distribution Share Analysis 43
7.2 GlobalData Consulting 43
7.3 Contact Us 44
7.4 Disclaimer 44

1.1 List of Tables
Table 1: Haematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Haematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Haemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 7: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 8: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 10: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 11: Haemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 12: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 13: Haematology Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 33
Table 14: Haematology Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 35
Table 15: Haematology Market Pipeline Products 38
Table 16: Orphee Terminates Distribution Agreement with PZ Cormay 39
Table 17: NoemaLife Enters into Distribution Agreement with Horiba Medical 40

1.2 List of Figures
Figure 1: Haematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Haematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Haemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 7: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 8: Haematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Haematology Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 10: Haematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 11: Haemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 12: Immunohaematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 13: Haematology Market, Russia, Company Share (%) 2014 34

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.